Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The 2016 WHO versus 2008 WHO Criteria for the Diagnosis of Chronic Myelomonocytic Leukemia.

Annals of laboratory medicine - 1 Sept 2018

Moon Yeonsook, Kim Mi Hyang, Kim Hye Ryoun, Ahn Jeong Yeal, Huh Jungwon, Huh Ji Young, Han Jae Ho, Park Joon Seong, Cho Sung Ran

Abstract excerpt

The 2016 WHO diagnostic criteria for chronic myelomonocytic leukemia (CMML) require both absolute and relative monocytosis (≥1×10⁹/L and ≥10% of white blood cell counts) in peripheral blood. Moreover, myeloproliferative neoplasm (MPN) features in bone marrow and/or MPN-associated mutations tend to support MPN with monocytosis rather than CMML. We assessed the impact of the 2016 WHO criteria on CMML diagnosis,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Janus Kinase 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myelomonocytic, Chronic

Share to Monocytes

Share to Myeloproliferative Disorders

Share to Platelet Count

Share to Trisomy

Share to World Health Organization

Source

Open in PubMed Open full text

Identifiers

PMID: 29797820
DOI: 10.3343/alm.2018.38.5.481
PMCID: PMC5973924

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The 2016 WHO versus 2008 WHO Criteria for the Diagnosis of Chronic Myelomonocytic Leukemia.PMID 29797820Read ↗

How I investigate chronic myelomonocytic leukemia.Semantic proximity Read ↗

Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Oligo-monocytic CMML and other pre-CMML states: Clinical impact, prognostication and management.Semantic proximity Read ↗

The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis.Semantic proximity Read ↗

Laboratory Evaluation and Pathological Workup of Neoplastic Monocytosis - Chronic Myelomonocytic Leukemia and Beyond.Semantic proximity Read ↗

Evolving Understanding of Chronic Myelomonocytic Leukemia: Implications for Future Treatment Paradigms.Semantic proximity Read ↗

[Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment].Semantic proximity Read ↗

[CURRENT CRITERIA FOR THE DIAGNOSIS OF MYELOPROLIFERATIVE NEOPLASMS - WHAT IS IMPORTANT TO KNOW?]Semantic proximity Read ↗

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.Semantic proximity Read ↗

The 2008 World Health Organization classification system for myeloproliferative neoplasmsSemantic proximity Read ↗

Prodromal myeloproliferative neoplasms: the 2008 WHO classification.Semantic proximity Read ↗

Chronic Myelomonocytic Leukemia: Insights into Biology, Prognostic Factors, and Treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.